N-Nonyldeoxynojirimycin (Synonyms: NN-DNJ, Nonyl-DNJ) |
| Katalog-Nr.GC14155 |
N-Nonyldeoxynojirimycin (NN-DNJ) ist ein starker Inhibitor von Alpha-Glucosidase und Alpha-1,6-Glucosidase (IC50s, 0,42 bzw. 8,4 μM) und hemmt den Glykogenabbau.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 81117-35-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
N-Nonyldeoxynojirimycin (NN-DNJ) is a potent inhibitor of alpha-glucosidase and alpha-1,6-glucosidase (IC50s, 0.42, 8.4 μM, respectively), inhibits glycogen breakdown[1].
References:
[1]. Andersson U, et al. Inhibition of glycogen breakdown by imino sugars in vitro and in vivo. Biochem Pharmacol. 2004 Feb 15;67(4):697-705.
Average Rating: 5 (Based on Reviews and 7 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *